ArticleJournal of the Society for Cardiovascular Angiography & Interventions2025
Robotic-Assisted Percutaneous Coronary Intervention: Final Results of the PRECISION and PRECISION GRX Studies.
Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Robot-assisted versus manual percutaneous vascular interventions across vascular territories: a systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
- Operator radiation burden and periprocedural outcomes in robotic-assisted versus manual percutaneous coronary intervention: a meta-analysis.BMC surgery · 2026Pooled it
- Evaluating Patients' Profiles and Procedural Outcomes of Robotically Assisted Percutaneous Coronary Interventions: A Single Centre Experience.Journal of clinical medicine · 2026Article
- AI-Driven Robotic PCI: A Perception-to-Action Framework for Coronary Guidewire Control.Bioengineering (Basel, Switzerland) · 2026Article
- The robotic revolution in percutaneous coronary intervention: bridging the gap to clinical reality.AsiaIntervention · 2026Article
- ALARA+: Summit on Radiation and Orthopedic Risks in Fluoroscopic Laboratories.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Review
- Robotic-assisted percutaneous coronary intervention: current evidence and future directions.Frontiers in cardiovascular medicine · 2026Article
- Innovations in Diagnosis and Treatment of Coronary Artery Disease.Diagnostics (Basel, Switzerland) · 2025Review
- Advancements and challenges in autonomous endovascular interventional robotics: A comprehensive review.iScience · 2025Review
- Radial artery access in interventional cardiology: a review of current practices.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2025Review
- Robotic Percutaneous Coronary Intervention in Real-World Practice: Performance, Complexity, and Learning Curves in Focus.Journal of the Society for Cardiovascular Angiography & Interventions · 2025Article
- Response to the Letter to the Editor Regarding Robotic-Assisted Percutaneous Coronary Intervention.Journal of the Society for Cardiovascular Angiography & Interventions · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Robotic percutaneous coronary intervention (R-PCI) reduces occupational hazards for interventional cardiologists. However, there is a lack of clinical data in a large patient cohort. The aims of this study were to evaluate the safety and efficacy of R-PCI with both the first (CorPath 200) and second (CorPath GRX) (Corindus, Siemens Company) generation robotic systems. Methods: These prospective, multicenter, single-armed studies enrolled patients with symptomatic coronary artery disease from 2013-2017 (PRECISION; CorPath 200) and 2017-2020 (PRECISION GRX; CorPath GRX). The primary outcome measures were clinical success, defined as <30% residual stenosis in the absence of major adverse cardiovascular events, and technical success, defined as clinical success without conversion to manual PCI. Results: A total of 1734 R-PCI procedures (PRECISION: 754 procedures, 950 lesions; PRECISION GRX: 980 procedures, 1233 lesions) were performed. Clinical (96.9% and 98.1% PRECISION and PRECISION GRX respectively, Conclusions: This multicenter experience with R-PCI demonstrates high clinical and technical success for patients treated with either the first- or second-generation robotic platform. Clinical and technical success rates with the second-generation robotic platform were higher for several complex lesion types. These data support the safety and efficacy of R-PCI in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.